At Manningham Medical Centre, you can find all the data about Medical Research Council Myeloma Ix Trial. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


The Medical Research Council Myeloma IX trial: the impact on …

    https://pubmed.ncbi.nlm.nih.gov/21991938/
    Osteolytic bone disease is a hallmark of symptomatic multiple myeloma. Bisphosphonates have been the mainstay of treatment to preserve skeletal integrity and prevent skeletal …

Long-term follow-up of MRC Myeloma IX trial: Survival outcomes …

    https://pubmed.ncbi.nlm.nih.gov/23995858/
    Purpose: Medical Research Council (MRC) Myeloma IX was a phase III trial evaluating bisphosphonate and thalidomide-based therapy for newly diagnosed multiple …

Effects of induction and maintenance plus long-term ... - PubMed

    https://pubmed.ncbi.nlm.nih.gov/22498739/
    The Medical Research Council Myeloma IX Trial (ISRCTNG8454111) examined traditional and thalidomide-based induction and maintenance regimens …

The Medical Research Council Myeloma IX Trial: new clinical

    https://pubmed.ncbi.nlm.nih.gov/22130220/
    The Medical Research Council Myeloma IX Trial: new clinical insights on the anticancer effects of zoledronic acid in patients with multiple myeloma Clin Lymphoma Myeloma …

Long-term Follow-up of MRC Myeloma IX Trial: Survival …

    https://aacrjournals.org/clincancerres/article/19/21/6030/78224/Long-term-Follow-up-of-MRC-Myeloma-IX-Trial
    The Medical Research Council (MRC) Myeloma IX trial used a factorial design to evaluate bisphosphonate and thalidomide therapy in patients with newly …

The Medical Research Council Myeloma IX Trial: The Impact on …

    https://dash.lib.harvard.edu/handle/1/10297258
    Harvard Medical School; HMS Scholarly Articles; View Item; JavaScript is disabled for your browser. Some features of this site may not work without it. Search DASH. ... The …

The Medical Research Council Myeloma IX trial: the impact on …

    https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0609.2011.01721.x
    Osteolytic bone disease is a hallmark of symptomatic multiple myeloma. Bisphosphonates have been the mainstay of treatment to preserve skeletal integrity and prevent …

The Medical Research Council Myeloma IX trial: the impact …

    https://dash.harvard.edu/bitstream/handle/1/10297258/3267050.pdf?sequence=1
    Recently, the MRC Myeloma IX trial demonstrated for the first time improved survival and delayed disease progression with the use of an intravenous amino-bisphosphonate, …

A trial comparing treatments for myeloma (MRC Myeloma IX)

    https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-treatments-for-myeloma
    A trial comparing treatments for myeloma (MRC Myeloma IX) Cancer type: Blood cancers Myeloma Status: Results Phase: Phase 3 This trial was comparing different treatment …

(PDF) The Medical Research Council Myeloma IX …

    https://www.researchgate.net/publication/51711504_The_Medical_Research_Council_Myeloma_IX_trial_The_impact_on_treatment_paradigms
    Recently, the MRC Myeloma IX trial demonstrated for the first time improved survival and delayed disease progression with the use of an intravenous amino-bisphosphonate, zoledronic acid, vs....



Need more information about Medical Research Council Myeloma Ix Trial?

At Manningham Medical Centre, we collected data on more than just Medical Research Council Myeloma Ix Trial. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.